Connect Sign In
LabMind podcasts
Participants will learn current state-of-the art approaches to fungal diseases. |
June 22, 2026 |
Find a Truly Immersive Experience at the 3rd FDLC/ATLAS Course in Clinical Fungi Join ARUP for the 3rd FDLC/ATLAS Course in Clinical Fungi, bringing global experts together for six days of hands-on training in fungal identification and current approaches to diagnosing and managing fungal diseases. |
Following the implementation of an AI-based wet mount screening platform, Enterobius vermicularis (pinworm) detection increased fivefold. |
June 18, 2026 | The study, published in the Journal of Clinical Microbiology, highlights the increased sensitivity and advantages of AI-based screening compared with manual microscopy. |
Accurate and timely diagnosis is critical to guiding appropriate treatment and improving patient outcomes. |
June 16, 2026 |
Navigating Tickborne Disease Testing Amid Rising U.S. Tick Activity Tick activity has traditionally peaked during the warmer months but that seasonal window appears to be expanding. Changing climate patterns resulting in milder winters are allowing more ticks to survive, contributing to earlier emergence in the spring. |
Jonathan Genzen, MD, PhD, MBA, ARUP’s chief medical officer and senior director of governmental affairs, said the Enhancing CLIA Act is an intriguing step forward in considering future oversight of laboratory-developed tests. |
June 16, 2026 |
Clinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIA Newly introduced federal legislation would modernize oversight of lab-developed tests under the Clinical Laboratory Improvement Amendments but support innovation, transparency, and patient access. |
Clinicians should coordinate with local health departments for assistance with testing for suspected Andes hantavirus and Ebola Bundibugyo infections. |
June 10, 2026 |
ARUP Laboratories Monitors Andes Hantavirus and Ebola Outbreaks to Assess Laboratory Testing Needs Benjamin Bradley, MD, PhD, discusses the current risk of Andes hantavirus and Ebola Bundibugyo in the U.S., ARUP’s response, and testing recommendations. |
Foodborne illness can take hold quickly and often presents with acute gastrointestinal (GI) symptoms. |
June 4, 2026 |
ARUP Launches Bacterial Gastrointestinal Panels for Rapid Results and Faster Reporting ARUP has launched multiplex polymerase chain reaction bacterial gastrointestinal panels that detect common pathogens with faster turnaround times to support rapid diagnosis and public health response. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat